135 related articles for article (PubMed ID: 3130192)
1. Enhanced interferon production and lymphokine-activated cytotoxicity of human placental cells.
Chin TW; Ank BJ; Strom SR; Stiehm ER
Cell Immunol; 1988 Apr; 113(1):1-9. PubMed ID: 3130192
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic and cytotoxic characteristics of the immune cells of the human placenta.
Goldsobel A; Ank B; Spina C; Giorgi J; Stiehm ER
Cell Immunol; 1986 Feb; 97(2):335-43. PubMed ID: 3742613
[TBL] [Abstract][Full Text] [Related]
3. Decreased interleukin-12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-gamma, natural killer, and lymphokine-activated killer activity by IL-12 in cord blood mononuclear cells.
Lee SM; Suen Y; Chang L; Bruner V; Qian J; Indes J; Knoppel E; van de Ven C; Cairo MS
Blood; 1996 Aug; 88(3):945-54. PubMed ID: 8704253
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic studies in human newborns: lessened allogeneic cell-induced (augmented) cytotoxicity but strong lymphokine-activated cytotoxicity of cord mononuclear cells.
Chin TW; Ank BJ; Murakami D; Gill M; Spina C; Strom S; Stiehm ER
Cell Immunol; 1986 Dec; 103(2):241-51. PubMed ID: 2433051
[TBL] [Abstract][Full Text] [Related]
5. The regulation and biological activity of interleukin 12.
Lee SM; Suen Y; Qian J; Knoppel E; Cairo MS
Leuk Lymphoma; 1998 May; 29(5-6):427-38. PubMed ID: 9643557
[TBL] [Abstract][Full Text] [Related]
6. Effects of herpes simplex virus on induced cell-mediated cytotoxicity in neonates and adults.
Chin TW; Plaeger-Marshall S; Ank BJ; Pressman SR; Stiehm ER
Nat Immun Cell Growth Regul; 1991; 10(5):237-46. PubMed ID: 1661847
[TBL] [Abstract][Full Text] [Related]
7. Decreased interleukin-15 from activated cord versus adult peripheral blood mononuclear cells and the effect of interleukin-15 in upregulating antitumor immune activity and cytokine production in cord blood.
Qian JX; Lee SM; Suen Y; Knoppel E; van de Ven C; Cairo MS
Blood; 1997 Oct; 90(8):3106-17. PubMed ID: 9376592
[TBL] [Abstract][Full Text] [Related]
8. Interferon and lymphokine production by human placental and cord blood cells.
Kruse A; Rink L; Rutenfranz I; Kolanczyk B; Kirchner H
J Interferon Res; 1992 Apr; 12(2):113-7. PubMed ID: 1578185
[TBL] [Abstract][Full Text] [Related]
9. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
[TBL] [Abstract][Full Text] [Related]
10. Augmentation of cytotoxic activity by combination with interleukin 2 and interferon gamma.
Tsunoda T; Tanimura H; Yamaue H; Iwahashi M; Tani M; Tamai M; Noguchi K; Arii K; Hotta T
Nihon Geka Hokan; 1991 Nov; 60(6):396-405. PubMed ID: 1820012
[TBL] [Abstract][Full Text] [Related]
11. [Augmentation of cytotoxic activity by combination with interleukin 2 and interferon gamma].
Tsunoda T; Tanimura H; Yamaue H; Tani M; Iwahashi M
Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1110-8. PubMed ID: 2118938
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic and functional analysis of lymphokine-activated killer (LAK) cell clones. Ability of CD3+, LAK cell clones to produce interferon-gamma and tumor necrosis factor upon stimulation with tumor targets.
Chong AS; Aleksijevic A; Scuderi P; Hersh EM; Grimes WJ
Cancer Immunol Immunother; 1989; 29(4):270-8. PubMed ID: 2502310
[TBL] [Abstract][Full Text] [Related]
13. Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor.
Chong AS; Scuderi P; Grimes WJ; Hersh EM
J Immunol; 1989 Mar; 142(6):2133-9. PubMed ID: 2493506
[TBL] [Abstract][Full Text] [Related]
14. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma-treated K562 target cells distinguish functional NK cells from lymphokine-activated killer (LAK) cells.
Powell J; Stone J; Chan WC; Yang ZD; Leatherbury A; Sell KW; Wiktor-Jedrzejczak W; Ahmed-Ansari A
Cell Immunol; 1989 Feb; 118(2):250-64. PubMed ID: 2491960
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of recombinant human interferon-gamma and interleukin 2 on natural killer cell activity of peripheral blood in early human development.
Ueno Y; Miyawaki T; Seki H; Matsuda A; Taga K; Sato H; Taniguchi N
J Immunol; 1985 Jul; 135(1):180-4. PubMed ID: 3923100
[TBL] [Abstract][Full Text] [Related]
17. Influence of elevated temperature on natural killer cell activity, lymphokine-activated killer cell activity and lectin-dependent cytotoxicity of human umbilical cord blood and adult blood cells.
Shen RN; Lu L; Young P; Shidnia H; Hornback NB; Broxmeyer HE
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):821-6. PubMed ID: 8040029
[TBL] [Abstract][Full Text] [Related]
18. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer.
Baxevanis CN; Reclos GJ; Gritzapis AD; Dedousis GV; Missitzis I; Papamichail M
Cancer; 1993 Jul; 72(2):491-501. PubMed ID: 8319179
[TBL] [Abstract][Full Text] [Related]
19. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum.
Webb BJ; Bochan MR; Montel A; Padilla LM; Brahmi Z
Cell Immunol; 1994 Dec; 159(2):246-61. PubMed ID: 7994757
[TBL] [Abstract][Full Text] [Related]
20. Differential cytokine regulation of natural killer cell-mediated necrotic and apoptotic cytotoxicity.
Gardiner CM; Reen DJ
Immunology; 1998 Apr; 93(4):511-7. PubMed ID: 9659223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]